Ikarian Capital’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Hold |
265,769
| – | – | 0.06% | 74 |
|
|
2025
Q1 | $292K | Hold |
265,769
| – | – | 0.04% | 87 |
|
|
2024
Q4 | $457K | Sell |
265,769
-666
| -0.2% | -$1.15K | 0.06% | 87 |
|
|
2024
Q3 | $661K | Hold |
266,435
| – | – | 0.09% | 69 |
|
|
2024
Q2 | $645K | Hold |
266,435
| – | – | 0.11% | 63 |
|
|
2024
Q1 | $1.08M | Sell |
266,435
-48,830
| -15% | -$198K | 0.12% | 55 |
|
|
2023
Q4 | $1.21M | Hold |
315,265
| – | – | 0.11% | 45 |
|
|
2023
Q3 | $1.31M | Sell |
315,265
-339,680
| -52% | -$1.41M | 0.16% | 43 |
|
|
2023
Q2 | $3.15M | Buy |
654,945
+400,000
| +157% | +$1.92M | 0.5% | 25 |
|
|
2023
Q1 | $1.04M | Hold |
254,945
| – | – | 0.23% | 53 |
|
|
2022
Q4 | $1.38M | Sell |
254,945
-95,055
| -27% | -$513K | 0.33% | 33 |
|
|
2022
Q3 | $3.51M | Buy |
+350,000
| New | +$3.51M | 0.7% | 21 |
|